Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
52.81M
Cash
38.34M
Avg Qtr Burn
-2.572M
Short % of Float
2.49%
Insider Ownership
7.03%
Institutional Own.
26.69%
Qtr Updated
12/31/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
COYA 301 [Low Dose Interleukin-2 (LD IL-2)] Details Alzheimer's disease, Neurodegenerative disease | Phase 2 Update | |
COYA 302 Details Frontotemporal dementia | Phase 1 Update | |
COYA 302 Details Amyotrophic lateral sclerosis | IND Submission |